Metabolic engineering for microbial production of terpenoid products

Inventors

KUMARAN, Ajikumar Parayil • LIM, Ryan • Donald, Jason • TSENG, Hsien-Chung • Santos, Christine Nicole S. • PHILIPPE, Ryan

Assignees

Manus Bio Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-10774346-B2

Patent

Publication Date

2020-09-15

Expiration Date


Abstract

The invention relates to methods and bacterial strains for making terpene and terpenoid products, the bacterial strains having improved carbon pull through the MEP pathway and to a downstream recombinant synthesis pathway.

Core Innovation

The claimed engineered bacterial strain increases production of terpene or terpenoid products from isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) produced through an overexpressed methylerythritol phosphate pathway (MEP pathway). The strain comprises recombinant or modified IspG and IspH enzymes with balanced expression or activity to prevent intermediate HMBPP accumulation. In addition, the genetic modifications include enhanced electron supply or transfer alongside the inactivation, deletion, or reduced expression or activity of aceE or the aceE enzyme complex.

Balanced IspG and IspH expression improves product titers, whereas IspG expression alone increases HMBPP and reduces growth. Deletion or mutation of aceE, alongside electron-transfer modifications such as expression of ferredoxin or flavodoxin homologs, alters electron flow and increases specific product titers while reducing intermediate accumulation. The background section and the specific problem being solved are not explicitly described in the provided content.

Claims Coverage

The claim coverage identifies two independent claims featuring five inventive features directed to an engineered bacterial strain with modified MEP-pathway enzymes and electron-transfer components.

Bacterial strain producing terpene or terpenoid products

Claim 1 specifies an engineered bacterial strain comprising genetic modifications that increase production of terpene or terpenoid products from IPP and DMAPP produced through an MEP pathway comprising one or more overexpressed genes.

Balanced IspG and IspH expression or activity

Claim 1 requires recombinant or modified IspG and IspH enzymes with balanced expression or activity to prevent accumulation of the HMBPP intermediate.

Enhanced electron supply or transfer

Claim 1 requires a recombinant or modified gene encoding an enzyme that enhances the supply or transfer of electrons through the MEP pathway or to terpene or terpenoid products.

Reduced aceE activity

Claim 1 requires inactivation, deletion, or reduced expression or activity of aceE or the aceE enzyme complex.

Overexpression of electron-transfer proteins

Claim 16 specifies overexpression of one or more of a flavodoxin, flavodoxin reductase, ferredoxin, and ferredoxin reductase.

The claims cover an engineered bacterial strain configured for terpene or terpenoid production through the MEP pathway, combining balanced IspG and IspH activity, enhanced electron supply or transfer, reduced aceE activity, and overexpression of specified electron-transfer proteins.

Stated Advantages

Balanced or tuned expression of IspG and IspH improves product titers by more than threefold and prevents HMBPP accumulation that reduces growth.

Deletion or mutation of aceE increases product B, C, or D titers by approximately 1.2- to 1.9-fold in comparative analyses and substantially reduces extracellular MEcPP and pathway product accumulation.

Overexpressing pgpB increases farnesol titers.

Overexpression of YdbK improves terpenoid production and reduces MEcPP accumulation, with benefits depending on sufficient IspG and IspH expression.

Expression of electron-carrier proteins such as Cv.fdx, fldA, or homologous proteins enhances electron transfer and further increases product titers.

Documented Applications

Bacterial production of terpene or terpenoid products using precursors from the MEP pathway, including farnesene, amorphadiene, artemisinic acid, artemisinin, bisabolol, bisabolene, alpha-sinensal, beta-thujone, camphor, carveol, carvone, cineole, citral, citronellal, cubebol, geraniol, limonene, menthol, menthone, myrcene, nootkatone, nootkatol, patchouli, piperitone, rose oxide, sabinene, steviol, steviol glycoside, rebaudioside D, rebaudioside M, taxadiene, thymol, and valencene.

Fermentation-based production of diverse terpene and terpenoid ingredients for food, fragrance, sweetener, cosmetic, and other products.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.